HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haitao Ji Selected Research

Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)

8/2014nNOS inhibition during profound asphyxia reduces seizure burden and improves survival of striatal phenotypic neurons in preterm fetal sheep.
3/2013Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
7/2012Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.
4/2012Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.
1/2011Involvement of neuronal nitric oxide synthase in ongoing fetal brain injury following near-term rabbit hypoxia-ischemia.
1/2011Neuronal nitric oxide synthase inhibition prevents cerebral palsy following hypoxia-ischemia in fetal rabbits: comparison between JI-8 and 7-nitroindazole.
11/2010Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives.
3/2009Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.
2/2009Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.
2/2009Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haitao Ji Research Topics

Disease

23Neoplasms (Cancer)
05/2022 - 11/2009
10B-Cell Lymphoma (Lymphoma, B Cell)
05/2022 - 01/2015
7Neurodegenerative Diseases (Neurodegenerative Disease)
07/2012 - 03/2008
4Fibrosis (Cirrhosis)
11/2019 - 05/2012
4Glioblastoma (Glioblastoma Multiforme)
12/2013 - 11/2009
4Cerebral Palsy (Spastic Diplegia)
10/2012 - 02/2009
4Hypoxia (Hypoxemia)
10/2012 - 02/2009
4Ischemia
10/2012 - 02/2009
4Brain Injuries (Brain Injury)
01/2011 - 02/2009
3Neoplasm Metastasis (Metastasis)
01/2021 - 10/2018
3Carcinogenesis
01/2016 - 12/2011
3Glioma (Gliomas)
12/2011 - 11/2009
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2019 - 02/2013
2Asphyxia (Suffocation)
08/2014 - 12/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2021
1Colonic Neoplasms (Colon Cancer)
10/2018
1Breast Neoplasms (Breast Cancer)
10/2018
1Seizures (Absence Seizure)
12/2013
1Brain Neoplasms (Brain Tumor)
12/2013
1Melanoma (Melanoma, Malignant)
08/2013
1Nervous System Diseases (Neurological Disorders)
03/2013
1Stroke (Strokes)
03/2008

Drug/Important Bio-Agent (IBA)

18CateninsIBA
05/2022 - 07/2011
13Proteins (Proteins, Gene)FDA Link
05/2022 - 07/2013
11Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
08/2014 - 03/2008
7Cadherins (E-Cadherin)IBA
01/2021 - 02/2013
4Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2013 - 03/2009
3Pharmaceutical PreparationsIBA
01/2021 - 07/2013
3TCF Transcription FactorsIBA
11/2019 - 05/2012
2Peptides (Polypeptides)IBA
10/2021 - 01/2019
2Pyruvate KinaseIBA
12/2012 - 12/2011
2ErbB Receptors (EGF Receptor)IBA
12/2011 - 07/2011
2Epidermal Growth Factor (EGF)IBA
12/2011 - 07/2011
2Protein Isoforms (Isoforms)IBA
12/2011 - 04/2010
1compound 21IBA
05/2022
1Chelating AgentsIBA
10/2021
1Radioisotopes (Radionuclides)IBA
10/2021
1somatostatin receptor 2IBA
10/2021
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2021
1MetalsIBA
10/2021
1AcidsIBA
01/2021
1EstersIBA
11/2019
1diphenyl (biphenyl)IBA
12/2018
1Aldo-Keto ReductasesIBA
10/2018
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2018
1LipidsIBA
10/2018
1Inositol (Myoinositol)IBA
10/2018
1DiglyceridesIBA
10/2018
1triphosphoric acid (triphosphate)IBA
10/2018
1ras GTPase-Activating Proteins (ras-GAP)IBA
01/2016
1Casein Kinase II (Casein Kinase 2)IBA
12/2013
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
12/2013
1Arginine (L-Arginine)FDA Link
08/2013
1Cisplatin (Platino)FDA LinkGeneric
07/2013
1Tumor Viral Antigens (Large T Antigen)IBA
07/2013
1ManganeseIBA
10/2012
17-nitroindazoleIBA
01/2011
1Nitric Oxide Synthase (NO Synthase)IBA
04/2010
1alpha Catenin (alpha E-Catenin)IBA
11/2009
1beta CateninIBA
11/2009

Therapy/Procedure

5Therapeutics
10/2021 - 03/2013
1Chemoprevention
08/2013